Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
about
Improved Cardiovascular Disease Outcomes in Older AdultsFrailty is an independent prognostic marker in elderly patients with myocardial infarction.Management of myocardial infarction in the elderly. Insights from Spanish Minimum Basic Data Set.Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes.Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score.A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale.Gender-related differences in elderly patients with myocardial infarction in a European Centre.Frailty is a short-term prognostic marker in acute coronary syndrome of elderly patients.Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome.Acute care of severely frail elderly patients in a CGA-unit is associated with less functional decline than conventional acute care.Frailty and acute coronary syndrome: A structured literature review.Impact of delirium on postoperative frailty and long term cardiovascular events after cardiac surgery.Comparative analysis of the association between 35 frailty scores and cardiovascular events, cancer, and total mortality in an elderly general population in England: An observational study.What do we know about frailty in the acute care setting? A scoping review.Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery DiseaseJapan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
P2860
Q26766094-FEC896E8-AD28-4DC5-B606-EA114F56C472Q38657003-A6D4B795-CEF9-4E40-BBAE-6E4C6756F88DQ38676195-7EC1A0EE-8F52-4A6E-A5A1-4A9454F59C7BQ38689160-7C7AA785-9988-451E-85D5-8B5C5DDE96B0Q39360977-80E58241-DDA2-49BA-9F61-523F4EA26FE7Q39535747-81A708D4-DA51-4171-B1EC-998604E1D60DQ40314092-34EB0ECD-8ED7-461F-9648-2CF890C14855Q40793052-AB8A5C49-B2C5-4812-B567-EF4FFC1E6170Q41265453-A46A6116-C85C-4ED9-9F4A-B1C47DCEF45EQ41405212-97FE7CA2-42A8-45CA-9BD2-88855FCEA11EQ47731200-C6053873-ED83-4541-A34D-C99EEC232366Q48330687-AA7865E9-CDBD-440B-AAA9-D839B8DD7E48Q51759029-0021E0F5-329A-4CD2-994D-C3B5C8D11290Q55252846-C4D6C030-138C-4534-A0F8-D7CA0F7B87C8Q56384060-0427DAE4-D253-4E06-AB4D-7C444C9FA398Q58362346-16C9D7A0-801A-4E47-8957-E77C3FE5D42B
P2860
Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Frailty is associated with wor ...... Syndromes (TRILOGY ACS) trial.
@en
Frailty is associated with wor ...... anage Acute Coronary Syndromes
@nl
type
label
Frailty is associated with wor ...... Syndromes (TRILOGY ACS) trial.
@en
Frailty is associated with wor ...... anage Acute Coronary Syndromes
@nl
prefLabel
Frailty is associated with wor ...... Syndromes (TRILOGY ACS) trial.
@en
Frailty is associated with wor ...... anage Acute Coronary Syndromes
@nl
P2093
P2860
P50
P356
P1476
Frailty is associated with wor ...... Syndromes (TRILOGY ACS) trial.
@en
P2093
Derek D Cyr
Harvey D White
Karen P Alexander
Keith Aa Fox
Kenneth J Winters
TRILOGY ACS investigators
P2860
P304
P356
10.1177/2048872615581502
P50
P577
2015-04-20T00:00:00Z